These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 25103845)
41. [Pathogenesis of paraneoplastic neurological syndromes]. Tanaka K Brain Nerve; 2010 Apr; 62(4):309-18. PubMed ID: 20420170 [TBL] [Abstract][Full Text] [Related]
42. Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity. Yang S; Vervaert CE; Burch J; Grichnik J; Seigler HF; Darrow TL Int J Cancer; 1999 Nov; 83(4):532-40. PubMed ID: 10508491 [TBL] [Abstract][Full Text] [Related]
43. Impaired tumor rejection by memory CD8 T cells in mice with NKG2D dysfunction. André MC; Sigurdardottir D; Kuttruff S; Pömmerl B; Handgretinger R; Rammensee HG; Steinle A Int J Cancer; 2012 Oct; 131(7):1601-10. PubMed ID: 21607945 [TBL] [Abstract][Full Text] [Related]
44. Resting CD8 T cells recognize beta-galactosidase expressed in the immune-privileged retina and mediate autoimmune disease when activated. McPherson SW; Yang J; Chan CC; Dou C; Gregerson DS Immunology; 2003 Nov; 110(3):386-96. PubMed ID: 14632667 [TBL] [Abstract][Full Text] [Related]
45. Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle. Yang Y; Haecker SE; Su Q; Wilson JM Hum Mol Genet; 1996 Nov; 5(11):1703-12. PubMed ID: 8922997 [TBL] [Abstract][Full Text] [Related]
46. Theiler's virus infection of genetically susceptible mice induces central nervous system-infiltrating CTLs with no apparent viral or major myelin antigenic specificity. Lin X; Pease LR; Murray PD; Rodriguez M J Immunol; 1998 Jun; 160(11):5661-8. PubMed ID: 9605173 [TBL] [Abstract][Full Text] [Related]
47. Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo. Kleindienst P; Brocker T Immunology; 2005 Aug; 115(4):556-64. PubMed ID: 16011524 [TBL] [Abstract][Full Text] [Related]
48. CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo. Yamada A; Salama AD; Sho M; Najafian N; Ito T; Forman JP; Kewalramani R; Sandner S; Harada H; Clarkson MR; Mandelbrot DA; Sharpe AH; Oshima H; Yagita H; Chalasani G; Lakkis FG; Auchincloss H; Sayegh MH J Immunol; 2005 Feb; 174(3):1357-64. PubMed ID: 15661893 [TBL] [Abstract][Full Text] [Related]
50. Clonal expansions of pathogenic CD8+ effector cells in the CNS of myelin mutant mice. Leder C; Schwab N; Ip CW; Kroner A; Nave KA; Dornmair K; Martini R; Wiendl H Mol Cell Neurosci; 2007 Nov; 36(3):416-24. PubMed ID: 17889554 [TBL] [Abstract][Full Text] [Related]
51. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain. Skundric DS; Huston K; Shaw M; Tse HY; Raine CS Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038 [TBL] [Abstract][Full Text] [Related]
52. Direct in vivo evidence of CD4+ T cell requirement for CTL response and memory via pMHC-I targeting and CD40L signaling. Ahmed KA; Wang L; Munegowda MA; Mulligan SJ; Gordon JR; Griebel P; Xiang J J Leukoc Biol; 2012 Aug; 92(2):289-300. PubMed ID: 22544940 [TBL] [Abstract][Full Text] [Related]
53. Repertoire enhancement with adoptively transferred female lymphocytes controls the growth of pre-implanted murine prostate cancer. Jenq RR; Curran MA; Goldberg GL; Liu C; Allison JP; van den Brink MR PLoS One; 2012; 7(4):e35222. PubMed ID: 22493742 [TBL] [Abstract][Full Text] [Related]
54. CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells. Antony PA; Piccirillo CA; Akpinarli A; Finkelstein SE; Speiss PJ; Surman DR; Palmer DC; Chan CC; Klebanoff CA; Overwijk WW; Rosenberg SA; Restifo NP J Immunol; 2005 Mar; 174(5):2591-601. PubMed ID: 15728465 [TBL] [Abstract][Full Text] [Related]
55. CD4+ and CD8+ T cells are both needed to induce paraneoplastic neurological disease in a mouse model. Gebauer C; Pignolet B; Yshii L; Mauré E; Bauer J; Liblau R Oncoimmunology; 2017; 6(2):e1260212. PubMed ID: 28344867 [TBL] [Abstract][Full Text] [Related]
56. Antigen-specific tumor vaccine efficacy in vivo against prostate cancer with low class I MHC requires competent class II MHC. Neeley YC; McDonagh KT; Overwijk WW; Restifo NP; Sanda MG Prostate; 2002 Nov; 53(3):183-91. PubMed ID: 12386918 [TBL] [Abstract][Full Text] [Related]
57. CD4-directed peptide vaccination augments an antitumor response, but efficacy is limited by the number of CD8+ T cell precursors. Hanson HL; Kang SS; Norian LA; Matsui K; O'Mara LA; Allen PM J Immunol; 2004 Apr; 172(7):4215-24. PubMed ID: 15034034 [TBL] [Abstract][Full Text] [Related]
58. Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses. Worgall S; Busch A; Rivara M; Bonnyay D; Leopold PL; Merritt R; Hackett NR; Rovelink PW; Bruder JT; Wickham TJ; Kovesdi I; Crystal RG J Virol; 2004 Mar; 78(5):2572-80. PubMed ID: 14963160 [TBL] [Abstract][Full Text] [Related]
59. Aspergillus fumigatus extract differentially regulates antigen-specific CD4+ and CD8+ T cell responses to promote host immunity. Tao J; Segal BH; Eppolito C; Li Q; Dennis CG; Youn R; Shrikant PA J Leukoc Biol; 2006 Sep; 80(3):529-37. PubMed ID: 16793916 [TBL] [Abstract][Full Text] [Related]
60. Paraneoplastic neurologic disorders: windows into neuronal function and tumor immunity. Darnell RB Arch Neurol; 2004 Jan; 61(1):30-2. PubMed ID: 14732616 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]